The interferon-inducible, double-stranded RNA (dsRNA)-dependent protein kinase which phosphorylates an endogenous HeLa 69 kilodalton polypeptide or exogenous initiation factor eIF2 was inhibited during vaccinia virus infection. High interferon doses (20,000 reference units per ml) did not prevent this inhibition. The inhibition required protein synthesis but not viral DNA synthesis during infection, suggesting that an early vaccinia virus gene function was responsible. An active dsRNA-dependent protein kinase could be recovered from an inactive extract by purification on polyinosinate -polycytidylatecellulose. An inhibitor of the protein kinase, therefore, must be present in the inactive extract. Similar results have been obtained with mouse L929 cells. At early time points of infection, the protein kinase in cell extracts required exogenous dsRNA for activity. This argues against endogenous viral dsRNA and activation of the kinase in the intact cell. At late time points of infection (when vaccinia virus dsRNA was almost certainly formed), the inhibitor of the kinase is present. Accordingly, it seems unlikely that the kinase played any role in the interferon-mediated inhibition of virus growth observed in these cells under these particular conditions.
The interferon-inducible, double-stranded RNA (dsRNA)-dependent protein kinase which phosphorylates an endogenous HeLa 69 kilodalton polypeptide or exogenous initiation factor eIF2 was inhibited during vaccinia virus infection. High interferon doses (20,000 reference units per ml) did not prevent this inhibition. The inhibition required protein synthesis but not viral DNA synthesis during infection, suggesting that an early vaccinia virus gene function was responsible. An active dsRNA-dependent protein kinase could be recovered from an inactive extract by purification on polyinosinate -polycytidylatecellulose. An inhibitor of the protein kinase, therefore, must be present in the inactive extract. Similar results have been obtained with mouse L929 cells. At early time points of infection, the protein kinase in cell extracts required exogenous dsRNA for activity. This argues against endogenous viral dsRNA and activation of the kinase in the intact cell. At late time points of infection (when vaccinia virus dsRNA was almost certainly formed), the inhibitor of the kinase is present. Accordingly, it seems unlikely that the kinase played any role in the interferon-mediated inhibition of virus growth observed in these cells under these particular conditions.
Protein synthesis in extracts from interferon-treated cells is unusually sensitive to inhibition by double-stranded RNA (dsRNA) (9) . Two distinct pathways of translational control, both regulated by interferon and dsRNA, have been identified: the protein kinase and 2-5A [ppp(A2'p),A; n -2] systems (reviewed in references 1 and 13). In cell-free systems, the dsRNA-dependent protein kinase is capable of phosphorylating the a-subunit of the eucaryotic protein synthesis initiation factor eIF2 (12, 19, 24) with a consequent inhibition of protein synthesis (4) . It also phosphorylates histones and an endogenous 69-kilodalton (K) (human) or 67K (mouse) polypeptide. These latter may be autophosphorylations, as purification has failed to separate the kinase from its 69K or 67K polypeptide substrates (6, 10, 20) . The importance of the kinase in interferon action remains to be established, but the enzyme has recently been shown to be active in interferon-treated, reovirus-infected cells (5, 17) .
We investigated both the kinase and the 2-5A systems in interferon-treated and control cells infected with vaccinia virus. We report here our results for the kinase system; those for the 2-5A system are presented in the accompanying paper (18) .
MATERIALS AND METHODS
Cells, virus, and interferon. HeLa and L929 cells were grown in monolayer cultures in Dulbecco modified Eagle medium supplemented with 10% heat-inactivated newborn calf serum. Vaccinia virus (strain WR) was grown essentially as described by Hruby et al. (7) . Interferon, interferon treatment, and infections were as described in Rice et al. (18) . For infections in the presence of inhibitors, cells were treated for 15 min before the addition of virus with either cycloheximide at 100 ,ug/ml or cytosine arabinoside at 40 ,ug/ml. These concentrations of the drugs were present in the culture medium throughout infection. Their effectiveness was checked as described in the accompanying paper (18 samples (15 ,u) of the supernatants were analyzed by electrophoresis on SDS-polyacrylamide gels.
Phosphatase assays. Proteins were labeled with [-y-32P]ATP in a kinase reaction as above using a cytoplasmic extract prepared from interferon-treated (400 reference units [r.u.] per ml) HeLa cells. Portions (6 ,u) were mixed with various cytoplasmic extracts (9 ,ul) , and magnesium acetate, unlabeled ATP, and poly(I) * poly(C) were added to final concentrations of 10 mM, 100 ,uM, and 1 ,ug/ml respectively, in a final volume of 18 RI. Aliquots (5 ,ul) incubated for 0, 5, 10, and 20 min at 30°C were analyzed by electrophoresis in SDSpolyacrylamide gels (10%).
RESULTS
Under the conditions of infection used in the experiments described here, vaccinia virus DNA synthesis began, in a one-step growth cycle, at ca. 2.5 h p.i. and was complete by 5 h. The maximum yield of virus occurred by 14 h. Early (DNA synthesis-independent) viral transcription occurred before DNA synthesis, with the onset of which late (DNA synthesis-dependent) viral transcription commences. In the accompanying paper, we have shown that high levels of 2-5A are synthesized in interferon-treated, vaccinia virusinfected cells from 5 h p.i. onwards, implying the formation of vaccinia dsRNA from late transcripts. This, in turn, suggests that the kinase should be activated to cause a total shutdown of protein synthesis. No such inhibition has been observed (18) . It was of interest, therefore, to determine whether the kinase was present and activatable.
Inhibition of the protein kinase in response to vaccinia infection. (i) Results with endogenous substrate. Protein kinase activities were assayed in extracts from interferontreated and control HeLa cells at 0 (mock-infected), 2, 5, and 8 h p.i. with vaccinia virus. The polypeptides labeled on incubation with [,y32P ]ATP for 15 min at 30°C were analyzed by electrophoresis in SDS-polyacrylamide gels (Fig. 1) . In mock-infected extracts (lanes 10 and 11), the labeled 69-kilodalton (K) polypeptide was that previously identified as the substrate of the interferon-mediated, dsRNA-dependent protein kinase (19, 20, 24) ; its level of phosphorylation in the interferon-treated cell extract was ca. two-to fivefold greater than in the corresponding control extract. Phosphorylation of the 69K polypeptide was dependent upon the addition of exogenous dsRNA [poly(I) * poly(C); compare Fig. 1 , lanes 2 to 9 with lanes 10 to 17]. In both interferon-treated and control cell extracts, the amount of label incorporated into the 69K polypeptide decreased as vaccinia virus infection proceeded until by 8 h p.i., none was detectable in either extract ( Fig. 1, lanes 14 and 17) . Identical results were obtained in mouse L929 cells (data not shown). The inhibition was specific for the 69K polypeptide ( Fig. 1) and cannot, therefore, simply reflect the induction of an ATPase. In addition, the results of control experiments in which the kinetics of labeling were followed or prelabeled extracts were incubated with those from control or infected cells argue against the activation of a protein phosphatase. In the latter, for example, an extract prelabeled in the kinase reaction with [y-2P]ATP was incubated with extracts from control or vaccinia virus-infected cells in the presence of excess unlabeled ATP. There was no preferential loss of the interferon and dsRNA-dependent label from the 69K polypeptide upon incubation with extracts from infected cells (Fig. 2) .
A 37K polypeptide was also labeled in the kinase reactions in the extracts from both interferon-treated and control cells at 5 and 8 h p.i. Phosphorylation of the 37K polypeptide did not require the addition of dsRNA to the reactions (Fig. 1,  lanes 5, 6, 8, and 9) . Moreover, labeling of the 37K polypeptide in extracts required protein synthesis, but not viral DNA synthesis during infection (see below). These results suggest that the 37K polypeptide is a viral polypeptide substrate for a dsRNA-independent protein kinase, possibly identical to the 37.5K polypeptide of Kleiman and Moss (11) . The time p.i. at which it was first detected was variable ( Fig. 1 and 4) . (ii) Results with added eIF2. The failure to incorporate label into the 69K polypeptide in extracts prepared at late times during infection could represent an inhibition of the dsRNA-activated protein kinase. Alternatively, it could be explained by the previous complete and stable phosphorylation of the 69K polypeptide by a fully activated protein kinase in the intact infected cell. To distinguish between these possibilities, we added purified eIF2 to the assays to serve as an exogenous substrate ( Fig. 3 and 4) .
In extracts from HeLa cells at 0 (Fig. 3 ylation of the 35K a.-subunit of eIF2 was observed. However, at 5 and 8 h p.i., it was no longer detectable in either interferon-treated or control cell extracts (lanes 13, 14, 16, and 17), confirming that the kinase was, in fact, inhibited. Figure 3 also shows a direct correlation between the amount of label incorporated into the endogenous HeLa 69K polypeptide and exogenous a-subunit of eIF2. This indicates that phosphorylation of the endogenous 69K polypeptide is a suitable assay for the interferon-mediated, dsRNA-dependent protein kinase activity in vaccinia virus-infected HeLa cell extracts.
Similar results were obtained with corresponding extracts from mouse L929 cells and added eIF2 (Fig. 4) . High concentrations of interferon do not prevent the vaccinia-induced inhibition of the dsRNA-dependent protein kinase activity. In the experiments shown in Fig. 1 to 4 , the cytoplasmic extracts were prepared from control cells and cells treated with 400 r.u. of interferon per ml. Under our current conditions, this concentration of homologous interferon gives HeLa and L929 cells full protection against encephalomyocarditis virus infection as judged by cytopathic effect or a vital dye uptake assay, but only inhibits vaccinia virus yield by 10%. In a one-step infectious cycle, up to 20,000 r.u./ml are required for a 90% inhibition in HeLa cells (18) . Accordingly, HeLa cells were treated with 0, 400, 2,000, and 20,000 r.u. of interferon per ml, and extracts were assayed at time points after vaccinia infection (Fig. 5A and B) to determine whether inhibition of the kinase was prevented at interferon concentrations sufficient to inhibit vaccinia virus growth.
There was either no detectable or greatly reduced phosphorylation of the endogenous 69K polypeptide in the extracts at 8 h p.i. (Fig. 5A, lanes 5, 9, 13 , and 17). Even with high interferon treatment, the dsRNA-dependent protein kinase was, therefore, inhibited during vaccinia infection. In the extract prepared from cells treated with 20,000 r.u. of interferon per ml, there was at 5 h p.i. significantly greater labeling of the 69K polypeptide than in the corresponding extracts from cells treated with lower levels of interferon (Fig. SA, compare lane 16 with lanes 8 and 12) . This higher level may be explained by either a greater induction of the protein kinase, a greater inhibition of viral protein synthesis, or both in response to high doses of interferon. The former would result in a higher level of enzyme requiring more time (or virus product) for inhibition; the latter would result in reduced viral function and effectiveness in the inhibition observed.
Additional points of interest are illustrated by the reactions incubated without the addition of exogenous dsRNA (Fig. SB) . In no instance was the 69K polypeptide phosphorylated without the addition of exogenous dsRNA. From this, 2 5 2 5 2 5 2 5 2 5 2 1 ,ug of poly(I) * poly(C) per ml. The markers to the right (A) and left (B) of the gels were as in Fig. 4. we concluded that it was unlikely that, before its inhibition, the dsRNA-dependent protein kinase was activated in the intact cell at early times during infection by endogenous viral dsRNA. Additionally, there was no detectable phosphorylation of the 37K polypeptide in extracts prepared at 8 h p.i. from cells treated with 20,000 r.u. of interferon (Fig. SA and  B, lanes 17) ; this is consistent with the 37K polypeptide being a viral polypeptide whose synthesis is inhibited by high interferon treatment (18) .
Expression of vaccinia early gene products is necessary for the inhibition of the dsRNA-dependent protein kinase. To determine whether the inhibition of the kinase requires protein synthesis, viral DNA synthesis, or both, infections were carried out in the presence of cycloheximide to inhibit protein synthesis or cytosine arabinoside to inhibit DNA synthesis. Extracts were prepared from interferon-treated (400 r.u./mi) an0 control cells at 0 (mock-infected), 2, and 5 h p.i. (Fig. 6 ). Vaccinia DNA synthesis was not required for inhibition of the protein kinase, as this occurred in extracts prepared 5 h p.i. in the presence of cytosine arabinoside (Fig. 6A, lanes AC, 9, 10, 15, and 16 ). However, protein synthesis is required as phosphorylation of the 69K polypeptide was not inhibited by cycloheximide (Fig. 6A, lanes CH,  11, 12, 17, and 18) . These results suggest that the expression of an early viral gene product is responsible for inactivation of the protein kinase.
With extracts prepared from cells infected in the presence of cycloheximide, there was no absolute requirement for added dsRNA for 69K kinase activity (Fig. 6B, lanes 12, 13,  18, and 19) . This is the only instance The positions to which molecular weight markers migrated are indicated to the right and left of the gels. Autoradiographs of the dried gels are presented.
when exogenous dsRNA was not required for activation of the 69K polypeptide kinase (see below). Consistent with a viral origin, phosphorylation of the 37K polypeptide requires protein, but not viral DNA, synthesis during infection (Fig. 6A, lanes 10 and 12; Fig. 6B, lanes 11  and 13) .
Recovery of active kinase from inactive vaccinia virusinfected extracts by adsorption onto poly(I) * poly(C)-cellulose. The interferon-mediated, dsRNA-dependent protein kinase has not yet been separated on purification from its 69K (human) or 67K (mouse) polypeptide substrates. It is possible that phosphorylation of these substrates are autophosphorylations. The kinase (and its substrate) can be purified by binding to poly(I) poly(C)-cellulose and is active in the bound state (6) . Accordingly, we used this procedure to determine whether an active dsRNA-dependent protein kinase could be purified from vaccinia virusinfected cell extracts which themselves have no activity.
Extracts from interferon-treated (400 r.u./ml) mock-infected (Fig. 7A, lanes A and A') or vaccinia virus-infected (8 h p.i.; Fig. 7A, lanes B and B' ) HeLa cells were incubated for 30 min in the presence or absence of poly(I) * poly(C)-cellulose. The poly(I) * poly(C)-cellulose-bound enzyme was harvested by centrifugation, washed three times, and assayed for kinase activity (Fig. 7A, lanes A' and B' ) in parallel with the non-poly(I) * poly(C)-treated material (Fig. 7A,  lanes A and B) . (For the experiments shown in Fig. 7 , dsRNA was included in all of the assays.) In the absence of any treatment with poly(I) * poly(C)-cellulose, phosphorylation of the 69K polypeptide occurred normally in the mockinfected extract (Fig. 7A, lane A) but was inhibited as usual in the infected extract (Fig. 7A, lane B) . After adsorption to poly(I) * poly(C)-cellulose, however, phosphorylation of the 69K polypeptide was observed with material from both extracts (Fig. 7A, lanes A' and B' ). Similar results were obtained with extracts from mock-infected and infected cells treated with 2,000 (Fig. 7B, lanes C, D, C' , and D') and 20,000 (Fig. 7B , lanes E, F, E', and F'). It can be concluded that inhibition of the kinase reflected the presence of an inhibitor in vaccinia virus-infected cell extracts.
The amounts of label incorporated into the 69K polypeptide bound to poly(I) * poly(C)-cellulose was greater with material from infected than from mock-infected extracts (Fig. 7A, compare Fig. 5 and 6 ). Moreover, active protein kinase can be recovered from inactive extracts by adsorption on poly(I) * poly(C)-cellulose (Fig. 7) . These results suggest that an early vaccinia gene product is responsible for the inhibition observed. It is unlikely that this product is a vaccinia virus-coded protein phosphatase (Fig. 2) . Its nature remains to be established.
Thacore and Youngner have observed in coinfection experiments that vaccinia rescued vesicular stomatitis virus from the inhibitory effects of interferon. They concluded that the effect was mediated by an early vaccinia virus gene product (21) . It is possible that the vaccinia virus-induced inactivation of the dsRNA-dependent protein kinase is responsible, although effects of the co-infection on other interferon antiviral mechanisms cannot be excluded.
Treatment of HeLa cells with up to 20,000 r.u. of interferon per ml did not prevent the inhibition of the kinase (Fig. 4) . (Fig. 6) . Infection in the presence of cycloheximide results in prolonged early transcription (14, 23) which, in turn, may give rise to low levels of (aberrant) early viral dsRNA. Alternatively, a low level of late dsRNA synthesis may escape the cycloheximide block. These levels of dsRNA will be much lower than the levels of late viral dsRNA formed in the absence of the drug, but they will be sufficient (in the absence of a kinase inhibitor) to trigger kinase activation. Consistent with this, as described in the accompanying paper (18), 2-5A was found in significant amounts in HeLa cells infected in the presence of cycloheximide, although the levels were low relative to those in infections in the absence of drugs, i.e., 50 nM compared with 3,000 nM at 9 h p.i. (18) . Putting these results together with those showing a requirement for protein synthesis for the formation of the inhibitor of the kinase (Fig. 6 ), it could be that the only situation in which it will be possible to obtain direct evidence for activation of the kinase in the intact cell in this system will be when vaccinia virus infection after interferon treatment is carried out in the presence of cycloheximide. It is of interest in this connection that Moss and Filler (15) (2, 3, 16) . It is possible that these are related phenomena and that the dsRNA-dependent kinase is involved.
It is interesting to speculate why vaccinia encodes or induces a cellular function which inactivates the dsRNAdependent protein kinase. From studies in cell-free systems, it seems likely that conditions which lead to activation of the 2-5A synthetase will also activate the kinase (e.g., reference 22). We have found high levels of 2-5A late (.5 h p.i.) in vaccinia infection (18) , implying that viral dsRNA exists in the infected cell at a time when the majority of late viral protein synthesis is occurring. Accordingly, if a dsRNAdependent protein kinase were present, one would expect it to be activated at that time with a consequent phosphorylation of eIF2 and inhibition of protein synthesis and virus growth. It should be remembered that although interferon induces increased levels of the dsRNA-dependent kinase, most cells contain significant endogenous levels (e.g., Fig.  1 ). With or without interferon to contend with, it would, therefore, be beneficial for vaccinia virus to prevent the dsRNA-dependent protein kinase from functioning and causing a general inhibition of protein synthesis.
